Tuberculous Mycobacteria in Patients with Cystic Fibrosis
This study led by Dr Andrew Burke, aims to provide answers as to how drugs for the treatment of MABSC and other NTM pathogens such as MAC are metabolized so that safer and more effective treatment guidelines can be established for people with cystic fibrosis.